daratumumab
janssen
the induction for ndmm session featured an insightful abstract presentation by dr. philippe moreau on using dara in transplant-ineligible ndmm, identifying optimal treatment durations, mrd-based dosage de-escalation, and when or if to drop to a singular therapeutic. #ims2022 
To cure myeloma by fostering research, education and excellence in clinical care worldwide.